Preclinical CRO Industry News

November 2026

Nov 2

Charles River Laboratories International (CRL) Gains Fresh Attention After Research Partnerships Raise Valuation Questions

Simply Wall St

Nov 2

Ascletis to Present Study Results of Oral Small Molecule GIPR Agonist ASC48 and GLP-1R/GIPR/GCGR Triple Peptide Agonist ASC37 at ObesityWeek® 2026

PR Newswire

Nov 2

Charles River Laboratories International, Inc. (0ADA.L) Seasonal Returns Chart - Yahoo Finance

Yahoo! Finance Canada

Nov 1

How AI Testing Partnerships Will Impact Charles River Stock

Simply Wall St

October 2026

Oct 31

Will CROs Emerge as the Biggest Winners? AI Reshapes Pharmaceutical Organizational Paradigms: The Rise of the "One-Person Pipeline"

富途牛牛

Oct 31

A Look at Charles River Laboratories International Inc (CRL) Aft

GuruFocus

Oct 30

Charles River Laboratories International, Inc. (CRL) Seasonal returns chart

Yahoo Finance UK

Oct 30

Top Players Charles River Laboratories, The Jackson

openPR.com

Oct 30

Atsena Therapeutics Reports New Preclinical Data Demonstrating Robust MYO7A Expression and Favorable Safety for ATSN-301, a Laterally Spreading Dual AAV Vector-based Gene Therapy for Usher Syndrome Type 1B

GlobeNewswire

Oct 30

Latus Bio Announces New Preclinical Data Featuring High-Performing Engineered AAV Capsid Variants for Kidney and CNS Diseases at ESGCT 33rd Annual Congress

Business Wire

Oct 30

Charles River (CRL) Stock Could Be 27% Overvalued As Preclinical FDA Collaboration Starts

Yahoo Finance

Oct 30

Charles River Laboratories (CRL) Expands Virtual Control Group Use In Toxicology Studies

Yahoo Finance

Oct 29

Preclinical CRO - Global Market Size, Share, Trends, and

GlobeNewswire

Oct 29

IDBS and a-tune strengthen long-standing partnership to connect Preclinical workflows

PR Newswire

Oct 29

Charles River Laboratories stock hits 52-week high at $378.01

Investing.com

Oct 29

Flagship brings 3 biotech platforms together to launch AI drug discovery player Etcelera

Fierce Biotech

Oct 29

Xenon Announces Positive Phase 1 and New Preclinical Data

GlobeNewswire

Oct 29

AviadoBio Presents New Preclinical Data Validating the vMiX™ Platform for AVB-406 in Alzheimer’s Disease and for AVB-SNCA in Parkinson’s Disease at ESGCT 2026

Business Wire

Oct 29

Charles River Laboratories stock hits 52-week high at $378.01 By Investing.com

Investing.com South Africa

Oct 28

Charles River Laboratories International Inc (CRL) Stock Up 4.2% but GF Value Says Overvalued -- GF Score: 64/100

GuruFocus

Oct 28

Rabbits Left to Die Overnight, Others Fatally Injured at Inotiv-Owned Indiana Facility: PETA Statement

People for the Ethical Treatment of Animals (PETA)

Oct 28

Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors despite daily gains

MarketWatch

Oct 28

Charles River Laboratories rises as new Ipsen study collaboration boosts focus on VCG platform

Quiver Quantitative

Oct 28

Charles River Laboratories (CRL) Earnings Expected to Grow: Should You Buy?

Yahoo! Finance Canada

Oct 28

ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming Conferences

GlobeNewswire

Oct 28

HotSpot Therapeutics to Present Preclinical Data on Small Molecule IRF5 Inhibitor HST-2011 at ACR Convergence 2026

PR Newswire

Oct 28

Latus Bio Announces the Publication of a Predictive Computational Model of Huntington’s Disease (HD) Built on Human Data Along with Validating Preclinical Data, Supporting LTS-201 as a Potential Best-in-Class, Disease-Modifying Therapy for HD

Business Wire

Oct 28

Astellas makes $1.3B bet on Audax’s preclinical push to reverse decades of IL-12 woes

Fierce Biotech

Oct 28

Charles River Leverages Virtual Control Groups in GLP Studies

BioSpace

Oct 27

Charles River Laboratories (CRL) Ticks Up 0.44% to $358.84, Holding Near Range Midpoint - Volume Nodes

https://www.siam.in/